|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Product revenue | |||||
| Service and other revenue | |||||
| Total revenue | |||||
| Cost of Revenue: | |||||
| Cost of revenue | |||||
| Product revenue | |||||
| Service and other revenue | |||||
| Cost of service and other revenue | |||||
| Amortization of acquired intangible assets | |||||
| Loss on purchase commitment | |||||
| Total cost of revenue | |||||
| Gross profit | |||||
| Operating Expense: | |||||
| Research and development | |||||
| Sales, general and administrative | |||||
| Impairment charges | |||||
| Merger-related expenses | |||||
| Amortization of acquired intangible assets | |||||
| Change in fair value of contingent consideration | |||||
| Total operating expense | |||||
| Operating loss | |||||
| Loss from Continuation Advances from Illumina | |||||
| Loss on extinguishment of debt | |||||
| Gain on debt restructuring | |||||
| Interest expense | |||||
| Other income, net | |||||
| Loss before income taxes | |||||
| Income tax provision (benefit) | |||||
| Net loss | |||||
| Other comprehensive income (loss): | |||||
| Unrealized gain on investments | |||||
| Comprehensive loss | |||||
| Net loss per share: | |||||
| Basic (in usd per share) | |||||
| Diluted (in usd per share) | |||||
| Weighted average shares outstanding used in calculating net loss per share: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...